LncRNA ZNNT1 induces p53 degradation by interfering with the interaction between p53 and the SART3-USP15 complex

Area of Science:

• Molecular Biology
• Cancer Research
• Genomics

Background:

• Long noncoding RNAs (lncRNAs) are crucial regulators of biological processes.
• Dysregulated lncRNAs are implicated in cancer development and progression.
• The role of specific lncRNAs, like ZNNT1, in colon cancer requires further investigation.

Purpose of the Study:

• To investigate the role of the lncRNA ZNNT1 in colon cancer proliferation and tumorigenicity.
• To elucidate the molecular mechanism by which ZNNT1 affects p53 protein stability.
• To explore ZNNT1 as a potential therapeutic target for colon cancer.

Main Methods:

• ZNNT1 knockdown experiments in colon cancer cells.
• Analysis of p53 ubiquitination and protein stabilization.
• Investigation of ZNNT1 interaction with SART3 and USP15.
• Assessment of colon cancer cell proliferation and tumorigenicity.

Main Results:

• ZNNT1 is essential for the proliferation and tumorigenicity of colon cancer cells with wild-type p53.
• ZNNT1 knockdown reduces p53 ubiquitination and increases its stabilization.
• ZNNT1 interacts with SART3 to destabilize p53, promoting colon cancer growth.
• ZNNT1 inhibits the SART3-USP15 interaction, leading to p53 destabilization.

Conclusions:

• ZNNT1 plays a critical role in colon cancer by destabilizing p53 protein through interaction with SART3 and USP15.
• ZNNT1 interference with p53 stabilization is key to promoting colon cancer cell proliferation and tumorigenicity.
• ZNNT1 represents a potential molecular target for colon cancer therapy.